Double maintains 1 strategies that include CATX - Perspective Therapeutics, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KURA | 47.76% | $617.78M | -63.55% | 0.00% |
VTYX | 31.25% | $96.74M | -79.20% | 0.00% |
DNTH | 30.36% | $623.55M | -37.37% | 0.00% |
LXRX | 30.15% | $132.09M | -82.76% | 0.00% |
SYRE | 28.24% | $1.15B | -50.57% | 0.00% |
IONS | 27.01% | $5.32B | -23.82% | 0.00% |
YMAB | 27.00% | $233.33M | -67.15% | 0.00% |
CAAP | 26.90% | $2.96B | +14.71% | 0.00% |
RXRX | 26.44% | $2.73B | -35.52% | 0.00% |
SPRY | 26.23% | $1.25B | +41.18% | 0.00% |
SVM | 26.22% | $876.19M | +31.27% | 0.60% |
IMNM | 25.75% | $708.65M | -66.04% | 0.00% |
FLGT | 25.60% | $522.87M | -23.40% | 0.00% |
ADPT | 25.54% | $1.29B | +177.56% | 0.00% |
FATE | 24.98% | $107.81M | -86.31% | 0.00% |
BNT | 24.83% | $7.12B | +32.87% | 0.00% |
ATXS | 24.61% | $359.49M | -56.81% | 0.00% |
EYPT | 24.54% | $435.74M | -70.77% | 0.00% |
CHMI | 24.46% | $115.75M | -2.66% | 16.44% |
NOK | 24.42% | $28.64B | +51.42% | 2.59% |
Yahoo
SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, announced today that the first patient was dosed in a new cohort of a Phase 1/2a trial evaluating the safety of [212Pb]VMT01, a targeted alpha-particle therapy (TAT), in patients with histologically confirmed melanoma and positive melanocortin 1 receptor
Finnhub
Perspective Therapeutics Inc: * PERSPECTIVE THERAPEUTICS ANNOUNCES FIRST PATIENT DOSEDWITHVMT01 IN COMBINATION WITH NIVOLUMAB IN A PHASE 1/2A STUDYOF MC1R-POSITIVE METASTATIC...
Yahoo
By John Vandermosten, CFA NASDAQ:LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) reported 2024 financial and operational results on February 26 th , producing sales of over $1 billion for Pylarify during the calendar year. Other products also made a material contribution including Definity, which rose almost 14% in part due to opportunistic sales. The company
Yahoo
SEATTLE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming investor conferences. TD Cowen 45th Annual Health Care Conference – Company Present
Yahoo
SEATTLE, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body, today announced that it will report its full year 2024 financial results and provide a business update on Wednesday, March 26, 2025 after the market closes. The press release will be available in the newsroom section of the Company's website at
Yahoo
SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming investor conferences. Oppenheimer's 35th Annual Healthcare Life Sciences Conference – Fireside
Current Value
$2.491 Year Return
Current Value
$2.491 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DDOG | <0.01% | $37.76B | -10.18% | 0.00% |
GIB | -0.01% | $22.51B | -8.65% | 0.21% |
SBAC | 0.02% | $23.53B | +0.14% | 1.86% |
IDXX | -0.03% | $34.45B | -20.03% | 0.00% |
STRA | -0.03% | $2.05B | -19.49% | 2.89% |
HIPO | -0.04% | $688.99M | +56.97% | 0.00% |
LAUR | 0.04% | $3.00B | +41.49% | 0.00% |
MSB | 0.05% | $368.67M | +54.31% | 25.00% |
UDR | 0.05% | $14.67B | +20.15% | 3.83% |
BTCT | -0.05% | $23.42M | +28.02% | 0.00% |
NTIC | -0.06% | $106.26M | -17.01% | 2.51% |
WM | -0.07% | $90.97B | +6.83% | 1.36% |
ATUS | 0.08% | $1.26B | +8.37% | 0.00% |
GLOB | -0.08% | $5.71B | -34.49% | 0.00% |
ZTS | -0.10% | $73.07B | -2.77% | 1.10% |
RBRK | -0.10% | $12.85B | +129.56% | 0.00% |
EE | 0.11% | $733.99M | +92.67% | 0.55% |
PSQH | 0.11% | $117.16M | -45.83% | 0.00% |
THS | 0.12% | $1.32B | -32.58% | 0.00% |
POST | 0.13% | $6.30B | +5.09% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SNOW | -28.83% | $53.86B | +3.18% | 0.00% |
PULM | -14.97% | $26.15M | +328.74% | 0.00% |
CRNC | -13.79% | $426.81M | -31.39% | 0.00% |
AOSL | -13.26% | $793.62M | +25.02% | 0.00% |
CBOE | -12.07% | $22.30B | +18.57% | 1.14% |
UTI | -11.88% | $1.49B | +81.89% | 0.00% |
SAVA | -11.81% | $135.26M | -85.79% | 0.00% |
MRK | -10.57% | $233.18B | -26.33% | 3.44% |
VSTS | -10.31% | $1.36B | -43.36% | 1.36% |
EW | -10.15% | $41.95B | -23.41% | 0.00% |
TEM | -9.87% | $10.16B | 0.00% | 0.00% |
TXNM | -9.82% | $5.03B | +47.44% | 2.90% |
WRB | -9.77% | $24.31B | +12.98% | 0.56% |
CHCT | -9.74% | $517.76M | -28.72% | 10.16% |
MCK | -9.20% | $82.82B | +24.09% | 0.41% |
BACK | -9.11% | $1.42M | -82.55% | 0.00% |
IBEX | -9.04% | $335.34M | +72.22% | 0.00% |
EXC | -8.80% | $44.00B | +18.26% | 3.55% |
WTW | -8.34% | $33.62B | +23.20% | 1.04% |
JNJ | -8.18% | $393.50B | +5.20% | 3.04% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPA | 38.67% | $284.92M | 0% |
CPRJ | 37.34% | $48.73M | 0.69% |
QQA | 34.69% | $170.26M | 0% |
CPSJ | 34.44% | $32.95M | 0.69% |
EFAA | 29.94% | $94.89M | 0% |
ARKG | 29.15% | $1.07B | 0.75% |
GNOM | 28.05% | $56.60M | 0.5% |
XBI | 27.18% | $5.71B | 0.35% |
CPSM | 26.54% | $64.63M | 0.69% |
DFIS | 26.17% | $2.70B | 0.39% |
ROBO | 25.37% | $1.00B | 0.95% |
SCZ | 25.36% | $9.26B | 0.4% |
FNDC | 25.03% | $3.23B | 0.39% |
ERTH | 24.48% | $143.97M | 0.67% |
HDRO | 24.31% | $164.26M | 0.3% |
AVDV | 24.12% | $7.71B | 0.36% |
GRID | 24.06% | $2.10B | 0.57% |
QCLN | 24.03% | $415.99M | 0.59% |
ROBT | 23.82% | $434.61M | 0.65% |
BBLU | 23.82% | $234.00M | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -19.39% | $195.31M | 0.85% |
TAIL | -19.37% | $83.56M | 0.59% |
WTMF | -18.39% | $157.34M | 0.65% |
BTAL | -18.36% | $392.84M | 1.43% |
UUP | -9.78% | $334.83M | 0.77% |
UNG | -9.31% | $423.53M | 1.06% |
USDU | -9.08% | $213.10M | 0.5% |
TFLO | -7.61% | $6.77B | 0.15% |
CTA | -7.42% | $941.51M | 0.76% |
GBIL | -6.50% | $6.18B | 0.12% |
TPMN | -6.02% | $33.22M | 0.65% |
KRBN | -5.67% | $176.79M | 0.85% |
EZBC | -5.35% | $415.93M | 0.29% |
ULST | -5.28% | $586.49M | 0.2% |
HODL | -5.17% | $1.20B | 0.25% |
BAB | -5.16% | $976.87M | 0.28% |
BITB | -5.13% | $3.22B | 0.2% |
BRRR | -5.09% | $509.36M | 0.25% |
FBTC | -5.06% | $16.46B | 0.25% |
GBTC | -5.04% | $16.24B | 1.5% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BNDW | 0.01% | $1.10B | 0.05% |
DBA | 0.03% | $836.02M | 0.93% |
TLTW | -0.05% | $1.13B | 0.35% |
CGCB | -0.06% | $1.94B | 0.27% |
UCON | -0.08% | $3.55B | 0.85% |
XLP | -0.11% | $16.21B | 0.09% |
BIL | -0.12% | $42.10B | 0.1356% |
SPMB | -0.16% | $5.94B | 0.04% |
GCOR | -0.17% | $356.29M | 0.08% |
IBTF | 0.19% | $2.24B | 0.07% |
JMBS | -0.20% | $5.13B | 0.23% |
VGIT | -0.22% | $31.07B | 0.03% |
TDTT | 0.28% | $2.35B | 0.18% |
IBTJ | 0.33% | $628.15M | 0.07% |
USTB | -0.33% | $1.12B | 0.35% |
SPTI | -0.41% | $7.70B | 0.03% |
XHLF | -0.42% | $1.06B | 0.03% |
AGZ | 0.45% | $644.40M | 0.2% |
GOVT | -0.47% | $27.30B | 0.05% |
IBTG | 0.47% | $1.81B | 0.07% |